Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Conjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics.

MacRedmond R, Singhera G, Attridge S, Bahzad M, Fava C, Lai Y, Hallstrand TS, Dorscheid DR.

Clin Exp Allergy. 2010 Jul;40(7):1071-8. doi: 10.1111/j.1365-2222.2010.03531.x.

PMID:
20642580
2.

Safety of dietary conjugated linoleic acid (CLA) in a 12-weeks trial in healthy overweight Japanese male volunteers.

Iwata T, Kamegai T, Yamauchi-Sato Y, Ogawa A, Kasai M, Aoyama T, Kondo K.

J Oleo Sci. 2007;56(10):517-25.

3.

Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese.

Gaullier JM, Halse J, Høivik HO, Høye K, Syvertsen C, Nurminiemi M, Hassfeld C, Einerhand A, O'Shea M, Gudmundsen O.

Br J Nutr. 2007 Mar;97(3):550-60.

PMID:
17313718
4.

The role of conjugated linoleic acid in reducing body fat and preventing holiday weight gain.

Watras AC, Buchholz AC, Close RN, Zhang Z, Schoeller DA.

Int J Obes (Lond). 2007 Mar;31(3):481-7. Epub 2006 Aug 22.

PMID:
16924272
5.

Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome components.

Laso N, Brugué E, Vidal J, Ros E, Arnaiz JA, Carné X, Vidal S, Mas S, Deulofeu R, Lafuente A.

Br J Nutr. 2007 Oct;98(4):860-7. Epub 2007 Jul 11.

PMID:
17623486
6.

Supplementation with conjugated linoleic acid for 24 months is well tolerated by and reduces body fat mass in healthy, overweight humans.

Gaullier JM, Halse J, Høye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O.

J Nutr. 2005 Apr;135(4):778-84.

7.

Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans.

Gaullier JM, Halse J, Høye K, Kristiansen K, Fagertun H, Vik H, Gudmundsen O.

Am J Clin Nutr. 2004 Jun;79(6):1118-25.

8.

Effect of conjugated linoleic acid supplementation after weight loss on appetite and food intake in overweight subjects.

Kamphuis MM, Lejeune MP, Saris WH, Westerterp-Plantenga MS.

Eur J Clin Nutr. 2003 Oct;57(10):1268-74.

PMID:
14506488
9.

Milk enriched with conjugated linoleic acid fails to alter blood lipids or body composition in moderately overweight, borderline hyperlipidemic individuals.

Venkatramanan S, Joseph SV, Chouinard PY, Jacques H, Farnworth ER, Jones PJ.

J Am Coll Nutr. 2010 Apr;29(2):152-9.

PMID:
20679151
10.

Dietary supplementation with cis-9,trans-11 conjugated linoleic acid and aortic stiffness in overweight and obese adults.

Sluijs I, Plantinga Y, de Roos B, Mennen LI, Bots ML.

Am J Clin Nutr. 2010 Jan;91(1):175-83. doi: 10.3945/ajcn.2009.28192. Epub 2009 Nov 18.

11.

Effects of dietary supplementation with conjugated linoleic acid on experimental human rhinovirus infection and illness.

Peterson KM, O'Shea M, Stam W, Mohede IC, Patrie JT, Hayden FG.

Antivir Ther. 2009;14(1):33-43.

PMID:
19320235
12.

Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain.

Larsen TM, Toubro S, Gudmundsen O, Astrup A.

Am J Clin Nutr. 2006 Mar;83(3):606-12.

13.

Effects of conjugated linoleic acid plus n-3 polyunsaturated fatty acids on insulin secretion and estimated insulin sensitivity in men.

Ahrén B, Mari A, Fyfe CL, Tsofliou F, Sneddon AA, Wahle KW, Winzell MS, Pacini G, Williams LM.

Eur J Clin Nutr. 2009 Jun;63(6):778-86. doi: 10.1038/ejcn.2008.45. Epub 2008 Sep 3.

PMID:
18772894
14.

Effect of a conjugated linoleic acid and omega-3 fatty acid mixture on body composition and adiponectin.

Sneddon AA, Tsofliou F, Fyfe CL, Matheson I, Jackson DM, Horgan G, Winzell MS, Wahle KW, Ahren B, Williams LM.

Obesity (Silver Spring). 2008 May;16(5):1019-24. doi: 10.1038/oby.2008.41. Epub 2008 Mar 6.

15.

Conjugated linoleic acid supplementation for twelve weeks increases lean body mass in obese humans.

Steck SE, Chalecki AM, Miller P, Conway J, Austin GL, Hardin JW, Albright CD, Thuillier P.

J Nutr. 2007 May;137(5):1188-93.

16.

The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.

Syvertsen C, Halse J, Høivik HO, Gaullier JM, Nurminiemi M, Kristiansen K, Einerhand A, O'Shea M, Gudmundsen O.

Int J Obes (Lond). 2007 Jul;31(7):1148-54. Epub 2006 Oct 10.

PMID:
17031391
17.

Safety profile of conjugated linoleic acid in a 12-month trial in obese humans.

Whigham LD, O'Shea M, Mohede IC, Walaski HP, Atkinson RL.

Food Chem Toxicol. 2004 Oct;42(10):1701-9.

PMID:
15354322
18.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
19.
20.

Conjugated linoleic acid supplementation alters the 6-mo change in fat oxidation during sleep.

Close RN, Schoeller DA, Watras AC, Nora EH.

Am J Clin Nutr. 2007 Sep;86(3):797-804.

Supplemental Content

Support Center